Objective: To determine the association of conventional cardiovascular risk factors, markers of platelet activation, and thrombogenic blood-borne microvesicles with white matter hyperintensity (WMH) load and progression in recently menopausal women.Methods: Women (n 5 95) enrolled in the Mayo Clinic Kronos Early Estrogen Prevention Study underwent MRI at baseline and at 18, 36, and 48 months after randomization to hormone treatments. Conventional cardiovascular risk factors, carotid intima-medial thickness, coronary arterial calcification, plasma lipids, markers of platelet activation, and thrombogenic microvesicles were measured at baseline. WMH volumes were calculated using a semiautomated segmentation algorithm based on fluid-attenuated inversion recovery MRI. Correlations of those parameters with baseline WMH and longitudinal change in WMH were adjusted for age, months past menopause, and APOE e4 status in linear regression analysis.Results: At baseline, WMH were present in all women. The WMH to white matter volume fraction at baseline was 0.88% (0.69%, 1.16%). WMH volume increased by 122.1 mm 3 (95% confidence interval: 2164.3, 539.5) at 36 months (p 5 0.003) and 155.4 mm 3 (95% confidence interval: 292.13, 599.4) at 48 months (p , 0.001). These increases correlated with numbers of platelet-derived and total thrombogenic microvesicles at baseline (p 5 0.03). White matter hyperintensities (WMH) observed in the aging brain are associated with small-vessel disease.
Conclusion:1,2 Although high WMH load may lead to mild cognitive impairment 3-6 and increase the risk of stroke, 7,8 little is known regarding the source or nature of cellular factors mediating their formation.
9Conventional cardiovascular risk factors such as hypertension, increasing age, smoking, hypercholesterolemia, and a history of cerebrovascular disease are the most consistent risk factors for the load and progression of WMH in elderly persons. 2,[10][11][12] In addition, thrombogenic risk factors including activated cell-derived microvesicles may contribute to formation of WMH, ischemic brain disease, and cognitive decline. [13][14][15][16] In recently menopausal women enrolled in the Kronos Early Estrogen Prevention Study (KEEPS), numbers of platelet-derived and thrombogenic (annexin V-positive) microvesicles correlated with carotid artery intima-medial thickness (CIMT). 17,18 Furthermore, CIMT correlated positively with the prevalence of WMH and poor cognitive performance. 19 Taken together, these studies suggest that cardiovascular risk factors, which may activate platelets to shed thrombogenic microvesicles, affect brain microstructure.